|
SKP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.36779999995829E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.86720000022933E-07 |
| Normal-vs-Stage2 |
3.130300E-02 |
| Normal-vs-Stage3 |
4.446100E-02 |
| Normal-vs-Stage4 |
2.041700E-03 |
| Stage1-vs-Stage2 |
2.622200E-01 |
| Stage1-vs-Stage3 |
1.069350E-01 |
| Stage1-vs-Stage4 |
5.453600E-01 |
| Stage2-vs-Stage3 |
7.868800E-01 |
| Stage2-vs-Stage4 |
6.008600E-01 |
| Stage3-vs-Stage4 |
3.941000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.8980999999817E-06 |
| Normal-vs-AfricanAmerican |
1.210750E-01 |
| Normal-vs-Asian |
5.653600E-02 |
| Caucasian-vs-AfricanAmerican |
7.183000E-01 |
| Caucasian-vs-Asian |
2.208400E-01 |
| AfricanAmerican-vs-Asian |
3.448400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.98689999999702E-05 |
| Normal-vs-Female |
4.45869999999848E-05 |
| Male-vs-Female |
5.414800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.975700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.18180000000068E-05 |
| Normal-vs-Age(61-80Yrs) |
7.65310000000463E-05 |
| Normal-vs-Age(81-100Yrs) |
6.375800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.317000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.764400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.018800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.776800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.721170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.698200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.74666999999129E-05 |
| Normal-vs-Grade 2 |
2.67110000007342E-07 |
| Normal-vs-Grade 3 |
2.842500E-03 |
| Normal-vs-Grade 4 |
2.442300E-02 |
| Grade 1-vs-Grade 2 |
1.854030E-01 |
| Grade 1-vs-Grade 3 |
1.897700E-02 |
| Grade 1-vs-Grade 4 |
2.902100E-02 |
| Grade 2-vs-Grade 3 |
1.462240E-01 |
| Grade 2-vs-Grade 4 |
2.754200E-01 |
| Grade 3-vs-Grade 4 |
9.879600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.89640000003433E-06 |
| Normal-vs-ccB subtype |
7.365800E-04 |
| ccA subtype-vs-ccB subtype |
9.704000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.80150000000424E-05 |
| Normal-vs-N1 |
9.985900E-02 |
| N0-vs-N1 |
4.003400E-01 |
|
|
